Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiru Liu

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Frontiers in Oncology|November 18, 2021
BI-RADS Reading of Non-Mass Lesions on DCE-MRI and Differential Diagnosis Performed by Radiomics and Deep LearningJiejie Zhou, Yan-Lin Liu, Yang Zhang, et al.
Scientific Data|February 7, 2026
Comprehensive Human Red Blood Cell Membrane and Cytoplasmic Proteome AnalysesXue Zhang, Huiru Liu, Qiuhong Zhang, et al.
Journal of Proteome Research|November 13, 2025
Plasma Fractionation and Mixture Improves Coverage in Proteomic AnalysisTing Liu, Han Chen, Yuning Song, et al.
Hepatology International|August 25, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort studyNingning Zhang, Kaipeng Liu, Yuexi Yu, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Frontiers in Oncology|November 18, 2021
BI-RADS Reading of Non-Mass Lesions on DCE-MRI and Differential Diagnosis Performed by Radiomics and Deep LearningJiejie Zhou, Yan-Lin Liu, Yang Zhang, et al.
Scientific Data|February 7, 2026
Comprehensive Human Red Blood Cell Membrane and Cytoplasmic Proteome AnalysesXue Zhang, Huiru Liu, Qiuhong Zhang, et al.
Journal of Proteome Research|November 13, 2025
Plasma Fractionation and Mixture Improves Coverage in Proteomic AnalysisTing Liu, Han Chen, Yuning Song, et al.
Hepatology International|August 25, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort studyNingning Zhang, Kaipeng Liu, Yuexi Yu, et al.
Pageof 6